Terms: = Prostate cancer AND uPA AND Treatment
79 results:
1. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
Clanchy FIL; Huang YS; Ogbechi J; Darlington LG; Williams RO; Stone TW
Front Immunol; 2022; 13():832989. PubMed ID: 35371018
[TBL] [Abstract] [Full Text] [Related]
2. RelB promotes the migration and invasion of prostate cancer DU145 cells via exosomal ICAM1 in vitro.
Li W; Xu J; Cheng L; Zhao C; Zhang L; Shao Q; Guo F
Cell Signal; 2022 Mar; 91():110221. PubMed ID: 34933092
[TBL] [Abstract] [Full Text] [Related]
3. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
[TBL] [Abstract] [Full Text] [Related]
4. Aspirin Inhibits IKK-β-mediated prostate cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract] [Full Text] [Related]
5. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (upa) in human prostate cancer cells.
Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
[TBL] [Abstract] [Full Text] [Related]
6. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract] [Full Text] [Related]
7. Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells.
Nambiar DK; Rajamani P; Singh RP
Biochem Biophys Res Commun; 2015 Jan; 456(1):262-8. PubMed ID: 25446081
[TBL] [Abstract] [Full Text] [Related]
8. The receptor for urokinase-plasminogen activator (upaR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract] [Full Text] [Related]
9. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Mahmoud AM; Yang W; Bosland MC
J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
[TBL] [Abstract] [Full Text] [Related]
10. Phenethyl isothiocyanate inhibits hypoxia-induced accumulation of HIF-1α and VEGF expression in human glioma cells.
Gupta B; Chiang L; Chae K; Lee DH
Food Chem; 2013 Dec; 141(3):1841-6. PubMed ID: 23870899
[TBL] [Abstract] [Full Text] [Related]
11. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract] [Full Text] [Related]
12. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.
Hafeez BB; Zhong W; Fischer JW; Mustafa A; Shi X; Meske L; Hong H; Cai W; Havighurst T; Kim K; Verma AK
Mol Oncol; 2013 Jun; 7(3):428-39. PubMed ID: 23273564
[TBL] [Abstract] [Full Text] [Related]
13. Selective photodetection and photodynamic therapy for prostate cancer through targeting of proteolytic activity.
Zuluaga MF; Sekkat N; Gabriel D; van den Bergh H; Lange N
Mol Cancer Ther; 2013 Mar; 12(3):306-13. PubMed ID: 23270928
[TBL] [Abstract] [Full Text] [Related]
14. [Effect of bisphosphonates on anticancer activity in prostate cancer cells].
Iguchi K
Yakugaku Zasshi; 2012; 132(9):1025-30. PubMed ID: 23023419
[TBL] [Abstract] [Full Text] [Related]
15. Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs.
Zuluaga MF; Gabriel D; Lange N
Mol Pharm; 2012 Jun; 9(6):1570-9. PubMed ID: 22548315
[TBL] [Abstract] [Full Text] [Related]
16. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract] [Full Text] [Related]
17. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Food Chem Toxicol; 2012 Mar; 50(3-4):840-7. PubMed ID: 22266361
[TBL] [Abstract] [Full Text] [Related]
18. Activation of pro-upa is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.
Bekes EM; Deryugina EI; Kupriyanova TA; Zajac E; Botkjaer KA; Andreasen PA; Quigley JP
Neoplasia; 2011 Sep; 13(9):806-21. PubMed ID: 21969814
[TBL] [Abstract] [Full Text] [Related]
19. Tumor markers in prostate cancer I: blood-based markers.
Shariat SF; Semjonow A; Lilja H; Savage C; Vickers AJ; Bjartell A
Acta Oncol; 2011 Jun; 50 Suppl 1(Suppl 1):61-75. PubMed ID: 21604943
[TBL] [Abstract] [Full Text] [Related]
20. Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling.
Kwon GT; Jung JI; Song HR; Woo EY; Jun JG; Kim JK; Her S; Park JH
J Nutr Biochem; 2012 Mar; 23(3):228-38. PubMed ID: 21497499
[TBL] [Abstract] [Full Text] [Related]
[Next]